Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Flebogamma

 
National Institutes of Health

Related topics

Related topics

4 relations
200 ML Immunoglobulin G, Human 50 MG/ML Injection [Flebogamma]50 ML Immunoglobulin G, Human 50 MG/ML Injection [Flebogamma]

Broader (2)

Immunoglobulin GImmunoglobulin G, Human

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Evaluation of the Efficacy and Safety of Griflow® Dual, a Pre-Set Two-Flow Infusion Device for Intravenous Immunoglobulin (Flebogamma® 5%) Administration
Purpose A single center, prospective study was performed to assess the efficacy and safety of Griflow® Dual–-a gravity-fed device… Expand
  • figure 1
  • figure 2
  • table I
  • table II
  • table III
Is this relevant?
2009
2009
Flebogamma 5% DIF development: rationale for a new option in intravenous immunoglobulin therapy.
Flebogamma 5% dual inactivation and filtration (DIF), a new 5% liquid intravenous immunoglobulin with a stability of 2 years when… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 3
Is this relevant?
2009
2009
Clinical experience with Flebogamma 5% DIF: a new generation of intravenous immunoglobulins in patients with primary immunodeficiency disease.
  • Mark Ballow
  • Clinical and experimental immunology
  • 2009
    • Corpus ID: 26342233
The development of effective, safe, liquid intravenous immunoglobulins (IVIG) preparations has represented a major therapeutic… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE